Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 32
Number of items: 32
  • Open Access
    Keijser, J. B. D., Tas, S. W., Verstegen, N. J. M., ten Brinke, A., van Ham, M. S., T2B! immunity against SARS-CoV-2 study group, & Löwenberg, M. (2025). Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment. eBioMedicine, 113, Article 105620. https://doi.org/10.1016/j.ebiom.2025.105620
  • Open Access
    Marino Vico, A. (2025). B cells and their signaling pathways: The guiding lights to decipher and target autoimmunity. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Frazzei, G. (2025). Predict to prevent: Targeting adaptive immune responses to decrease the risk of rheumatoid arthritis. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Kummer, L. Y. L., Kuijper, L. H., Fernández Blanco, L., Bos, A., Kreher, C., Verstegen, N. J. M., Duurland, M. C., Konijn, V. A. L., Jorritsma, T., Tempert, M., Menage, C., Steenhuis, M., van Gils, M. J., Claireaux, M., Garcia-Vallejo, J. J., D’Haens, G. R. A. M., Löwenberg, M., Volkers, A. G., van Dam, K. P. J., ... ten Brinke, A. (2025). TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination. RMD OPEN, 11(3), Article e005724. https://doi.org/10.1136/rmdopen-2025-005724
  • Open Access
    Valk, A. M., Tas, S. W., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination. Allergy, 79(7), 1952–1961. https://doi.org/10.1111/all.16089
  • Open Access
    Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J., Rispens, T., & T2B! immunity against SARS-CoV-2 study group (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology, 15, Article 1314507. https://doi.org/10.3389/fimmu.2024.1314507
  • Open Access
    Choi, I. Y. K. (2024). Biomarker research in rheumatoid arthritis: A special focus on S100 proteins. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M., ... T2B! immunity against SARS-CoV-2 study group (2024). Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. RMD OPEN, 10(4), Article e004664. https://doi.org/10.1136/rmdopen-2024-004664
  • Open Access
    Busold, S. (2024). Rewiring biology: Targeting dendritic cells to reset allergic disease. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Nagy, N. A. (2024). An untold tale of tolerance: Conditioning dendritic cells to restore immune balance using tolerogenic nanocarriers. [Thesis, fully internal, Universiteit van Amsterdam].
Page 1 of 4